You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 13, 2024

Details for New Drug Application (NDA): 040378

✉ Email this page to a colleague

« Back to Dashboard

NDA 040378 describes NIACOR, which is a drug marketed by Avondale Pharms and is included in one NDA. It is available from three suppliers. Additional details are available on the NIACOR profile page.

The generic ingredient in NIACOR is niacin. There are fourteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the niacin profile page.
Summary for 040378
Applicant:Avondale Pharms
Formulation / Manufacturing:see details
Pharmacology for NDA: 040378
Medical Subject Heading (MeSH) Categories for 040378
Suppliers and Packaging for NDA: 040378
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NIACOR niacin TABLET;ORAL 040378 ANDA Avondale Pharmaceuticals, LLC 71740-001 71740-001-10 100 TABLET in 1 BOTTLE (71740-001-10)
NIACOR niacin TABLET;ORAL 040378 ANDA Avondale Pharmaceuticals, LLC 71740-201 71740-201-10 100 TABLET in 1 BOTTLE (71740-201-10)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength500MG
Approval Date:May 3, 2000TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.